ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 010,93
-0,58%
Dow Jones
38 852,86
-0,55%
DAX
18 601,65
-0,44%
Brent Oil
84,605
0,33%
Bitcoin
67 800,70
-0,72%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) Actualités

BIAF bioAffinity Technologies Inc

2,54
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
bioAffinity Technologies Inc BIAF NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,54 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,54
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/5/202415:15BWbioAffinity Technologies Reports Record Q1 Revenue Driven by..
02/5/202414:00BWbioAffinity Technologies News Update
24/4/202414:00BWbioAffinity Technologies Advances New Product Development..
09/4/202414:00BWbioAffinity Technologies Expands Campaign to Support..
01/4/202415:49BWbioAffinity Technologies Reports Fourth Quarter and Full..
08/3/202423:00EDGAR2Form 8-K - Current report
08/3/202419:15PRNUSWallachbeth Capital Announces Closing of bioAffinity..
08/3/202418:45BWbioAffinity Technologies Announces Closing of $2.5 Million..
08/3/202418:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/3/202403:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/3/202416:45PRNUSWallachBeth Capital Announces Pricing of BioAffinity..
06/3/202415:46BWbioAffinity Technologies Announces Pricing of $2.5 Million..
05/3/202423:26EDGAR2Form 8-K - Current report
05/3/202414:00BWbioAffinity Technologies Reports Accelerating Sales Growth..
21/2/202414:00BWbioAffinity Technologies News Update
06/2/202414:00BWMedical Director of Lung Innovations Network and The Lung..
02/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:05EDGAR2Form 8-K - Current report
30/1/202414:00BWbioAffinity Technologies In The News
25/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202414:00BWbioAffinity Technologies Announces Award of Therapeutic..
08/1/202414:00BWbioAffinity Technologies In the News
08/12/202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202314:45EDGAR2Form 8-K - Current report
05/12/202314:00BWbioAffinity Technologies Appoints Jamie Platt, Ph.D., to its..
30/11/202315:20EDGAR2Form 8-K - Current report
30/11/202314:00BWCMS Posts Final Payment Determination for bioAffinity..
28/11/202322:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202314:00BWbioAffinity Technologies VP David Elzi, Ph.D., Named to..
28/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
16/11/202323:23EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202323:07EDGAR2Form 8-K - Current report
15/11/202314:00BWbioAffinity Technologies Teams with American Cancer Society..
14/11/202322:01BWbioAffinity Technologies Reports Third Quarter 2023..
14/11/202321:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202314:00BWbioAffinity Technologies Names Dallas J. Coleman as National..
03/11/202321:49EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202321:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
18/10/202323:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202323:27EDGAR2Form 8-K - Current report
10/10/202314:00BWbioAffinity Technologies to Present at the 8th Annual Dawson..
10/10/202312:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/9/202322:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/9/202323:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..

Dernières Valeurs Consultées

NASDAQ
BIAF
bioAffinity Technologies
BIT
P1U4D3
BNP Paribas Issuance
UNSW
ARCONAETH
Arcona Distribution Contract
GATE
REAPUSDT
ReapChain
BIT
P1GLD9
BNP Paribas Issuance
NYSE
GIZ
Lehman Bros Pie
BIT
F15388
Vontobel Financial Produ...
NASDAQ
CFFEU
CF Acquisition Corporati...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés